Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia

NCT01077375 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia

Interventions

DRUG: Placebo
DRUG: Milnacipran

Sponsor

Forest Laboratories

Collaborators

[object Object]